Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CEST
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; [email protected]

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
Stocks mentioned in the article
ChangeLast1st jan.
CARDINAL HEALTH -0.39% 62.07 Delayed Quote.1.70%
CVS HEALTH -0.37% 65.12 Delayed Quote.-9.16%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
04/20CVS HEALTH CORPORATION : To Hold First Quarter 2018 Conference Call
PR
04/20CVS PHARMACY : Offering Hepatitis A Vaccine to Kentuckians Following an Increase..
PR
04/20CVS HEALTH : Ex-dividend day for
FA
04/19CVS HEALTH : Expands Safe Drug Disposal at CVS Pharmacy Locations in Ohio to Hel..
PR
04/19CVS PHARMACY : Launches First Campaign Featuring Unaltered Beauty Imagery
PR
04/19CVS HEALTH : EX-Dividend Schedule: CVS Health Has a Dividend Yield of 3.03%; Wil..
AC
04/18CVS HEALTH : Phoenix VA Health Care System, TriWest and CVS Health Mark First An..
PR
04/18CVS HEALTH : Names Marc-David Munk, MD, MPH, MHCM, as Chief Medical Officer of M..
AQ
04/17UnitedHealth earnings ease investor worries over flu season, stock up
RE
04/17CVS HEALTH : Today’s Research Reports on Trending Tickers: CVS Health and Centen..
AC
More news
News from SeekingAlpha
04/21THE PASSIVE DGI CORE PORTFOLIO : Income, Safety, And Growth 
04/20Vilas Fund, LP Q1 '18 Letter To Partners - #28 Since Inception, Long Pharma 
04/1910 Dividend Growth Stocks For April 2018 
04/19Jelly Beans, Group Think, And Greenblatt's Magic Formula 
04/193 Cheap Dividend Stocks To Consider 
Financials ($)
Sales 2018 189 B
EBIT 2018 10 003 M
Net income 2018 5 761 M
Debt 2018 20 873 M
Yield 2018 3,31%
P/E ratio 2018 11,98
P/E ratio 2019 10,66
EV / Sales 2018 0,46x
EV / Sales 2019 0,43x
Capitalization 66 066 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 87,9 $
Spread / Average Target 35%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-9.16%66 066
WALGREENS BOOTS ALLIANCE-10.11%63 387
EXPRESS SCRIPTS HOLDING CO-1.54%41 267
MCKESSON CORPORATION-5.67%30 177
AMERISOURCEBERGEN-0.14%19 742
CARDINAL HEALTH1.70%19 534